RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer

Clinical trial NCT03681483 · COMPLETED

Trial details

NCT number: NCT03681483
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Non-small Cell Lung Cancer

Start date: 2018-10-31
Primary completion: 2024-07-08
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.